{"text": "<extra_id_0> Glucocorticoid receptors <extra_id_2> Protein <extra_id_1> are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease [ see comments ]", "event": "<extra_id_0> <extra_id_1>"}
{"text": "BACKGROUND : Growing evidence indicates that the immune system and the hypothalamic-pituitary-adrenal system are linked by several mechanisms , for example intracellular <extra_id_0> glucocorticoid receptors <extra_id_2> Protein <extra_id_1> ( <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Glucocorticoids are the standard treatment of acute attacks of inflammatory bowel disease ( IBD ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Binding of glucocorticoids to <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> down-regulates the transcription of inflammatory genes that can propagate IBD .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "PATIENTS AND METHODS : IBD patients were either treated with 5-60 mg of prednisolone for more than 1 week or were without glucocorticoid treatment for more than 4 weeks .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels were determined from isolated cytosol of peripheral blood mononuclear cells ( PBMCs ) or mucosal biopsies using a radioassay with [ 3H ] - dexamethasone .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> Interleukin (IL) 6 <extra_id_2> Protein <extra_id_1> levels were determined by enzyme - linked immunosorbent assay ( ELISA ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "RESULTS : The systemic ( PBMC ) <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels of corticosteroid - treated IBD patients were significantly lower than those of control subjects ( 59.6 +/- 57.1 dpm mg-1 cytosol protein vs . 227.0 +/- 90.8 dpm mg-1 cytosol protein , P = 0.007 ) and IBD patients not receiving glucocorticoid treatment ( 179.7 +/- 171.3 dpm mg-1 cytosol protein , P = 0.002 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Systemic <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels in untreated IBD patients did not differ significantly from those in control subjects .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In patients with connective tissue diseases , systemic <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels were also found to be decreased in the absence of glucocorticoid treatment .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Systemic <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels in patients with Crohn 's disease ( CD ) treated with steroids ( 66.6 +/- 61.0 dpm mg-1 cytosol protein ) were not different from those in patients with ulcerative colitis ( UC ) ( 56.1 +/- 51.6 dpm mg-1 cytosol protein ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In contrast to these findings , mucosal <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels were significantly decreased in both steroid - treated ( 18.0 +/- 15.5 ) and not steroid - treated ( 37.8 +/- 30.5 ) patients compared with control subjects ( 125.6 +/- 97.1 ; P = 0.00009 and P = 0.0008 respectively ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "<extra_id_0> IL-6 <extra_id_2> Protein <extra_id_1> levels in all IBD groups with and without steroids were significantly different from those in control subjects .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "CONCLUSION : In IBD there is no difference in systemic <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels between not steroid - treated patients and control subjects , in spite of inflammatory activity ( <extra_id_0> IL-6 <extra_id_2> Protein <extra_id_1> ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Mucosal <extra_id_0> hGR <extra_id_2> Protein <extra_id_1> levels were decreased independently of treatment , probably leading to a decreased protection against NF-kappaB action in the intestinal mucosa .", "event": "<extra_id_0> <extra_id_1>"}
